Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy
Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats
Tags: 5-fluorouracil (5-FU) prodrug, breast cancer, chemotherapy, colorectal cancer, fluoropyrimidine, gastric cancer, Xeloda®
BASi Method Number SAP.777
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
